H Honegger. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » AnimalsBenzalkonium Compounds/administration & dosageBenzalkonium Compounds/therapeutic useChemical PhenomenaChemistryConjunctivitis/drug therapyDrug CombinationsEye Diseases/chemically inducedEye Diseases/drug therapyHumansHyperemia/chemically inducedHyperemia/drug therapyImidazoles/administration & dosageImidazoles/therapeutic useLacrimal Duct Obstruction/drug therapyOphthalmic SolutionsRabbitsSilver NitrateSorbitol/administration & dosageSorbitol/therapeutic useTolazolineVasoconstrictor Agents/administration & dosageVasoconstrictor Agents/adverse effectsVasoconstrictor Agents/therapeutic use
Substances: See more » Benzalkonium CompoundsDrug CombinationsImidazolesOphthalmic SolutionsVasoconstrictor AgentsSorbitolSilver NitrateTolazoline
Year: 1972 PMID: 4646937
Source DB: PubMed Journal: Klin Monbl Augenheilkd ISSN: 0023-2165 Impact factor: 0.700